FN1 and cancer: Based on data provided by TCGA and GTEx, FN mRNA exhibits higher expression in primary tumors than in normal tissues in 17 out of 25 cancer types (68%) for 10 or more normal tissue and primary tumor samples (Figure 1B, Supplementary Table S4).